These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14193347)

  • 1. [VALUE OF THROMBELASTOGRAPHY IN THERAPEUTIC FIBRINOLYSIS OBTAINED USING A NICOTINIC ACID DERIVATIVE].
    PERRETTA A; PARANO JR; VILLA JJ
    Prensa Med Argent; 1964 Aug; 51():427-31. PubMed ID: 14193347
    [No Abstract]   [Full Text] [Related]  

  • 2. [INFLUENCE OF A NICOTINIC ACID DERIVATIVE ON FIBRINOLYTIC PROCESSES].
    PERICOLI F; NUZZI R
    Policlinico Prat; 1963 Nov; 70():1589-95. PubMed ID: 14115994
    [No Abstract]   [Full Text] [Related]  

  • 3. THE FIBRINOLYTIC RESPONSE TO NICOTINIC ACID IN ABNORMAL LIVER STATES.
    WEINER M
    Am J Med Sci; 1963 Sep; 246():294-300. PubMed ID: 14063746
    [No Abstract]   [Full Text] [Related]  

  • 4. [EFFECT OF INCREASED FIBRINOLYSIS ON PLASMA FIBRINOGEN; A HYPOTHESIS CONCERNING THE ORIGIN OF AFIBRINOGENEMIA].
    DE WIT CD; MOERS AM; DEN OTTOLANDERGJ
    Ned Tijdschr Geneeskd; 1964 Aug; 108():1482-5. PubMed ID: 14182799
    [No Abstract]   [Full Text] [Related]  

  • 5. [FIBRINOLYTIC CHEMOTHERAPY. FIRST RESULTS OF A PERSONAL EXPERIENCE].
    PERRIN A; FONTAINE L; SAINT-PIERRE A
    Lyon Med; 1964 Dec; 212():1551-60. PubMed ID: 14253644
    [No Abstract]   [Full Text] [Related]  

  • 6. [EXTENDED THERAPEUTIC POSSIBILITIES IN PERIPHERAL CIRCULATORY DISORDERS WITH SPECIAL RESPECT TO FIBRINOLYSIS ACTIVATION].
    LUCZAK S
    Chirurg; 1964 Dec; 35():546-8. PubMed ID: 14342271
    [No Abstract]   [Full Text] [Related]  

  • 7. [On thrombolysis studies on the rabbit with combined nicotinic acid-heparin therapy].
    SAILER S; EBER O
    Klin Wochenschr; 1960 Jun; 38():548-51. PubMed ID: 14440816
    [No Abstract]   [Full Text] [Related]  

  • 8. [APROPOS OF THROMBOLYTIC THERAPY].
    DONNER L
    Cas Lek Cesk; 1964 Jan; 103():102-7. PubMed ID: 14129510
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of proteolysis inhibitors from Ascaris lumbricoides on the coagulation and fibrinolysis of human plasma].
    Kadłubowski R; Ochecka A
    Angew Parasitol; 1982 May; 23(2):78-82. PubMed ID: 7125286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [THROMBOLYTIC THERAPY. CLINICAL TRIALS OF TREATMENT WITH PURIFIED STREPTOKINASE].
    ABASTADO M
    Bull Mem Soc Med Hop Paris; 1964 Jul; 115():941-57. PubMed ID: 14230879
    [No Abstract]   [Full Text] [Related]  

  • 11. [POSSIBILITIES AND ADVANTAGES OF FIBRINOLYTIC DRUGS IN THERAPY OF KIDNEY DISEASE IN PREGNANCY].
    MARZETTI L
    Quad Clin Ostet Ginecol; 1964 Jul; 19():346-52. PubMed ID: 14242595
    [No Abstract]   [Full Text] [Related]  

  • 12. [BETAIN NICOTINATE IN PROLONGED ORAL FIBRINOLYTIC THERAPY].
    FRANDOLI G; GIBELLI A; TURAZZA G
    Gazz Int Med Chir; 1964 Nov; 68():2065-83. PubMed ID: 14242275
    [No Abstract]   [Full Text] [Related]  

  • 13. STUDIES WITH COMPLAMIN, A NICOTINIC-ACID-THEOPHYLLINE ESTER, AS A FIBRINOLYTIC AGENT.
    MCNICOL GP; DOUGLAS AS
    Br Med J; 1965 May; 1(5443):1149-53. PubMed ID: 14273517
    [No Abstract]   [Full Text] [Related]  

  • 14. [THE COMBINED EFFECT OF FIBRINOLYSIS INHIBITORS].
    MARKWARDT F; KLOECKING HP; RICHTER M
    Acta Biol Med Ger; 1964; 12():522-4. PubMed ID: 14134957
    [No Abstract]   [Full Text] [Related]  

  • 15. [Activation of fibrinolysis by 3-pyridylacetic acid and nicotinic acid in man].
    GIBELLI A; SACCHETTI G; MAINIERI L; SOARDI F
    Acta Vitaminol; 1962; 16():107-19. PubMed ID: 13947690
    [No Abstract]   [Full Text] [Related]  

  • 16. [Fibrinolysis by nicotinic acid derivatives].
    Thies HA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1971; 95(2):216-9. PubMed ID: 4106011
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparative investigations on the effect of nicotinic acid alone and in association with a synthetic, heparin-like sulfated polyanion on fibrinolysis, platelet aggregation and lipidic fractions.
    Turazza G; Spreafico PL; Frandoli G
    Arzneimittelforschung; 1973 May; 23(5):654-7. PubMed ID: 4575777
    [No Abstract]   [Full Text] [Related]  

  • 18. [COAGULATION AND ANTICOAGULATION SYSTEM OF THE BLOOD AND ITS REACTION TO CORONARY CIRCULATION DISORDERS].
    IAROSHEVSKII AIa; ZHAVORONKOVA EK
    Ter Arkh; 1964 Jan; 36():36-42. PubMed ID: 14149441
    [No Abstract]   [Full Text] [Related]  

  • 19. [ON THE SANARELLI-SHWARTZMAN LOCAL PHENOMENON. I. INFLUENCE OF AN ASSOCIATION OF TRYPSIN, CHYMOTRYPSIN AND "TRIPSEPAR"].
    D AMICO G
    G Ital Chir; 1964 Mar; 20():191-217. PubMed ID: 14203868
    [No Abstract]   [Full Text] [Related]  

  • 20. [ON SOME CONCLUSIONS IN THE EXPERIMENTAL AND CLINICAL STUDY OF FIBRINOLYSIS].
    ANDREENKO GV
    Ter Arkh; 1963 Jul; 35():3-12. PubMed ID: 14077561
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.